ATM and breast cancer: In the current study, patient SM-46, who was found to carry an exon 4 deletion in the ATM gene, also had a pathogenic mutation in the BRCA2 gene; therefore, the involvement of the ATM intragenic deletion with breast cancer predisposition in this particular case remains to be clarified.